The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spectrum of clinical manifestations. As a result, the WHO disease classification of EVD underwent major revision.
This is a preview of subscription content
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kuhn, J. H. in Marburg- and Ebolaviruses — From Ecosystems to Molecules (eds Mühlberger, E., Hensley, L. L. & Towner, J. S.) 447–460 (Springer, 2017).
Fukuda, K., Wang, R. & Vallat, B. Naming diseases: first do no harm. Science 348, 643 (2015).
Kupferschmidt, K. Rules of the name. Science 348, 745 (2015).
The authors thank Laura Bollinger (US National Institutes of Health (NIH)/US National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility at Fort Detrick, Frederick, MD, USA) for critically reviewing the manuscript. This work was supported in part through Battelle Memorial Institute’s prime contract with the NIAID under Contract No. HHSN272200700016I (J.H.K.). This project was funded in part with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E (I.C.). G.I. is grateful for support from the Italian Ministry of Health, grant Ricerca Corrente, Research Programme n.1. The UK Public Health Rapid Support Team (D.G.B.) is funded by the UK Department of Health and Social Care.
The authors declare no competing interests.
The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official views, assertions, opinions or policies, either expressed or implied, of the US Department of Defense, US Department of Health and Human Services (National Institutes of Health; Centers for Disease Control and Prevention), US Uniformed Services University, UK National Health System, the UK National Institute for Health Research, the UK Department of Health and Social Care or of the institutions and companies affiliated with the authors. In no event shall any of these entities have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. Some authors are employees of the U.S. Government and as such under the provisions of 17 U.S.C. 105, copyright protection is not available for this work. Mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.
About this article
Cite this article
Kuhn, J.H., Adachi, T., Adhikari, N.K.J. et al. New filovirus disease classification and nomenclature. Nat Rev Microbiol 17, 261–263 (2019). https://doi.org/10.1038/s41579-019-0187-4
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
Nature Communications (2022)
Nature Reviews Disease Primers (2020)
Intensive Care Medicine (2020)
Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak
One Health Outlook (2020)
Virology Journal (2019)